50
Participants
Start Date
July 23, 2024
Primary Completion Date
May 1, 2028
Study Completion Date
May 1, 2028
Adebrelimab
"Drug: Adebrelimab Adebrelimab 1200mg will be given every 3 weeks for 3 cycles in induction chemotherapy and for 9 cycles in adjuvant chemotherapy, started on day 1 of induction chemotherapy and adjuvant chemotherapy, respectively.~Other Names:~PD-L1 antibody~Drug: Gemcitabine Gemcitabine 1g/m2, d1 \& 8 of every cycle, every 3 weeks for 3 cycles before radiation.~Other Names:~GEM~Drug: Cisplatin Induction cisplatin 80mg/m2, every 3 weeks for 3 cycles before radiation; Concurrent cisplatin 100mg/m2, every 3 weeks for 2 cycles during radiation~Other Names:~DDP~Radiation: Intensity-modulated radiotherapy Definitive intensity-modulated radiotherapy (IMRT) of 6996cGy will be given in 33 fractions.~Other Names:~IMRT"
RECRUITING
The First Affiliated Hospital of Xiamen University, Xiamen
RECRUITING
Nanfang Hospital, Southern Medical University, Guangzhou
RECRUITING
Sun Yat-sen University Cancer Center, Guangzhou
RECRUITING
West China Hospital, Sichuan University, Chengdu
Nanfang Hospital, Southern Medical University
OTHER
West China Hospital
OTHER
The First Affiliated Hospital of Xiamen University
OTHER
Sun Yat-sen University
OTHER